Stocks TelegraphStocks Telegraph
Stock Ideas

STOK Company Profile and Key Details

NASDAQ : STOK

Stoke Therapeutics, Inc.

$9.80
0.44+4.70%
At Close 4:00 PM
$10.02
0.22+2.24%
After-Market 04:00 PM
59.42
BESG ScoreESG Rating

STOK Stock Price Chart

Stock Price Today

Stoke Therapeutics, Inc. (STOK) stock surged +2.24%, trading at $10.02 on NASDAQ, up from the previous close of $9.80. The stock opened at $9.77, fluctuating between $9.66 and $10.43 in the recent session.

Stock Snapshot

9.8
Prev. Close
9.77
Open
530.73M
Market Cap
52.97M
Number of Shares
9.66
Day Low
10.43
Day High
-4.82
P/E Ratio
81.31%
Free Float in %
-2.08
EPS (TTM)
3.55
Book Value
-1.84
Cash Flow per Share
562.64K
Volume

Stock Price History Chart

DateOpenHighLowCloseVolume
Jan 21, 20259.479.829.309.80753.57K
Jan 17, 20259.559.659.359.36270.41K
Jan 16, 20259.599.598.989.46665.89K
Jan 15, 20259.049.778.819.491.41M
Jan 14, 20259.009.148.428.68916.9K
Jan 13, 20258.899.008.558.921.1M
Jan 10, 20259.009.118.779.001.61M
Jan 08, 20259.549.548.768.961.04M
Jan 07, 20259.8210.568.889.312.31M
Jan 06, 202511.5111.6310.9811.02388.29K
Jan 03, 202511.1811.7311.1811.49682.06K
Jan 02, 202511.1311.6810.9911.27403.4K
Dec 31, 202410.9611.0910.7711.03207K
Dec 30, 202410.8611.0910.5310.80510.35K
Dec 27, 202411.1211.5410.9111.06304.7K
Dec 26, 202411.2211.4611.0211.24425.38K
Dec 24, 202411.3511.6111.1011.32517.33K
Dec 23, 202411.5811.7911.3511.612.55M
Dec 20, 202410.8111.8410.8111.681.18M
Dec 19, 202411.2111.3410.6111.30660.61K

Contact Details

Bedford, MA 01730

United States

Website: https://www.stoketherapeutics.comContact: 781 430 8200

About Company

Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. Its lead clinical candidate is STK-001, which is in phase I/IIa clinical trial to treat Dravet syndrome, a severe and progressive genetic epilepsy; and STK-002, which is in preclinical stage for the treatment of autosomal dominant optic atrophy. It had entered into a license and collaboration agreement with Acadia Pharmaceuticals Inc. for the discovery, development, and commercialization of novel RNA-based medicines for the treatment of severe and rare genetic neurodevelopmental diseases of the central nervous system. The company was formerly known as ASOthera Pharmaceuticals, Inc. and changed its name to Stoke Therapeutics, Inc. in May 2016. Stoke Therapeutics, Inc. was incorporated in 2014 and is headquartered in Bedford, Massachusetts.

Company Information

Employees110
Beta0.95
Sales or Revenue$8.78M
5Y Sales Change%0%
Fiscal Year EndsDecember
SectorHealthcare
IndustryBiotechnology

Frequently Asked Questions

What is the current Stoke Therapeutics, Inc. (STOK) stock price?

Stoke Therapeutics, Inc. (NASDAQ: STOK) stock price is $10.02 in the last trading session. During the trading session, STOK stock reached the peak price of $10.43 while $9.66 was the lowest point it dropped to. The percentage change in STOK stock occurred in the recent session was 2.24% while the dollar amount for the price change in STOK stock was $0.22.

STOK's industry and sector of operation?

The NASDAQ listed STOK is part of Biotechnology industry that operates in the broader Healthcare sector. Stoke Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of STOK?

Ms. Shamim Ruff
Chief Regulatory Officer
Dr. Edward M. Kaye M.D., Ph.D.
Chief Executive Officer & Director
Ms. Dawn Kalmar
Chief Communications Officer
Ms. Joan Wood
Chief HR Officer
Dr. Adrian R. Krainer Ph.D.
Co-Founder, Independent Director & Member of Scientific Advisory Board
Mr. Stephen J. Tulipano CPA, CPA, MBA
Chief Financial Officer
Ms. Isabel Aznarez Ph.D.
Co-Founder & Group Vice President of Discovery Research
Dr. Huw M. Nash Ph.D.
Chief Operating Officer & Chief Bus. Officer
Mr. Eric Rojas
Head of Investor Relations
Mr. Jonathan Allan J.D.
Corporation Sec. & Gen. Counsel

How STOK did perform over past 52-week?

STOK's closing price is 139.61% higher than its 52-week low of $4.09 where as its distance from 52-week high of $17.58 is -44.26%.

How many employees does STOK have?

Number of STOK employees currently stands at 110.

Link for STOK official website?

Official Website of STOK is: https://www.stoketherapeutics.com

How do I contact STOK?

STOK could be contacted at phone 781 430 8200 and can also be accessed through its website. STOK operates from 45 Wiggins Avenue, Bedford, MA 01730, United States.

How many shares of STOK are traded daily?

STOK stock volume for the day was 562.64K shares. The average number of STOK shares traded daily for last 3 months was 664.08K.

What is the market cap of STOK currently?

The market value of STOK currently stands at $530.73M with its latest stock price at $10.02 and 52.97M of its shares outstanding.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph